Lisa Nolan Joins Rexahn Pharmaceuticals
Executive Summary
Cancer focused Rexahn Pharmaceuticals Inc. has appointed Lisa Nolan to the newly created position of chief business officer (CBO). She previously held similar positions at Relmada Therapeutics and Topigen Pharmaceuticals, where she was CBO, and SkyePharma, where she was vice president, global business development and strategic marketing. Nolan has also been managing director of Nolex Advisors LLC.